Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 551 results for "drl"

Sensex gains 363 points, Nifty ends above 8,350; DRL, HDFC surge
IBN Live

Sensex gains 363 points, Nifty ends above 8,350; DRL, HDFC surge

The market has kick-started the week on a positive note. The Sensex is up 79.82 points or at 27403.82 and the Nifty is up 22.90 points at 8285.25. About 384 shares have advanced, 121 shares declined, and 76 shares are unchanged. Hindalco, ONGC, Cipla, GAIL ... IBN Live, 5 days ago

19 images for drl, 2 days ago
IBN Live, 5 days ago, 3 weeks ago, 2 weeks ago, 3 weeks ago, 3 weeks ago, 3 weeks ago, 3 weeks ago
CBC, 1 month ago, 3 weeks ago

Upcoming Maruti Suzuki Ciaz with LED DRL likely to boost sales in India

The Ciaz sedan from Maruti Suzuki has been one of the most promising sedan from India's popular carmaker Maruti Suzuki. Recently news had been doing rounds that Maruti Suzuki has been working on developing a special edition of Ciaz that may sport ...
 CarTrade.com1 week ago Maruti Suzuki Ciaz to get a special edition?  CarTrade.com1 week ago Maruti Suzuki will introduce three products this year  CarDekho4 weeks ago

Accumulate Dr Reddys Labs; target of Rs 3957: KRChoksey

KRChoksey is bullish on Dr Reddys Laboratories (DRL) and has recommended accumulate rating on the stock with a target price of Rs 3957 in its research report dated May 13, 2015.
 Money Control1 week ago Buy DRL as UCB buy incrementally positive  Financial Express1 month ago 'Buy' Dr Reddy's Lab; target Rs 4,075: Reliance Securities  MyIris3 days ago Dr Reddy's: Good show across geographies  Business Standard India1 week ago

DRL launches Somazina for stroke patients in India

Partners with global innovator of Citicoline, Ferrer Internacional, Spain, to make Somazina available in India Dr Reddy's Laboratories (DRL) has launched Somazina, the innovator brand of Citicoline in the Indian market. DRL has partnered with ...
 CPhI.cn5 days ago
India Infoline

Dr Reddy's Laboratories launches cerebral stroke drug

DRL brought Somazina to India in partnership with Ferrer Internacional SA of Spain. Photo: Mint Hyderabad: Dr Reddy's Laboratories Ltd (DRL) on Friday said it had launched cerebral stroke management drug Somazina in the Indian market. The drug is ...
 Livemint.com1 week ago BRIEF: Dr Reddy's Laboratories launches cerebral stroke drug [Mint, New Delhi]  Bloomberg1 week ago Dr Reddy Laboratories : TO LAUNCH HEPATITIS C DRUG IN INDIA  4 Traders2 months ago Dr Reddy's Laboratories posts flat profit for FY 2015  Deccan Chronicle1 week ago

DRL Q4 net rises 8% on higher sales

Buoyed by higher sale of generics and new product launches, Dr Reddy's Laboratories (DRL) has reported a consolidated net profit of R519 crore for Q4, an increase of 8% from R482 crore a year earlier. The consolidated net sales improved by 11.2% to ...
 Financial Express1 week ago Dr Reddy's Labs consolidated net up by 7.7% in Q4, final dividend of 400%  PharmaBiz1 week ago DRL ties up with Taxus Cardium  The Financial Chronicle1 month ago Dr Reddy's Net Up 8 Percentage to Rs 519 crore  New Indian Express1 week ago

Dr Reddy's Labs PAT seen grow by 14.3% yoy: Angel Broking

Dr Reddys Laboratories (DRL), an integrated global pharmaceutical company, will be announcing its fourth quarter financial results today, May. 12, 2015. ''DRL is expected to post a growth of 16.4% yoy to Rs 40.52 billion, mainly driven by the ...
 MyIris1 week ago DRL, Promius Pharma files NDAs with US FDA  Financial Express1 month ago Dr Reddy's Laboratories files 3 new drug applications in US  Deccan Chronicle1 month ago DRL opens formulation development laboratory  Financial Express2 months ago

Worst over for Indian mkt; like ICICI Bk, DRL: Asianomics

Now since China has already seen a strong move, people would wait for consolidation to add further exposure there and would focus on India, says Chris Roberts of Asianomics.
 Money Control1 week ago
The Telegraph

Eye significant growth in acquired UCB drugs: Dr Reddy's

According to Alok Sonig of DRL, the acquired brands have grown historically at lower double-digits and have a lot of headroom to grow further
 Money Control1 month ago DRL to acquire select portfolio of UCB's products business in India  Financial Express1 month ago DRL to buy UCB brands for Rs 800 crore  Times of India1 month ago DRL buys Belgian UCB's select brands in India  Times of India1 month ago

DRL discloses robust product pipeline: Nomura

Dr Reddy's Laboratories (DRL) has disclosed that it has made three NDA filings with the US FDA, more than its earlier indications for 1-2 NDA filings by end-FY15. Unlike ANDAs, the timeline for approval of NDAs is shorter, hence approval can come ...
 Financial Express1 month ago DRL and its subsidiary Promius Pharma files three NDAs with US FDA  Financial Express1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less